NCT03256981 2023-12-26
HALT
Institute of Cancer Research, United Kingdom
Phase 2/3 Unknown
Clinical Trials
4 trialsNCT03799094 2019-01-10
Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations
Clifford Hospital, Guangzhou, China
Phase 1/2 Unknown
NCT03424980 2018-02-08
A Study to Evaluate Effectiveness and Safety of Tyrosine Kinase Inhibitors
Tang-Du Hospital
Unknown
NCT02906163 2016-09-19
First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy
SciClone Pharmaceuticals
Phase 1/2 Unknown